165.61 USD
-1.9 (-1.13%)
165.61 USD
0 (0%)
Taking everything into account, WGS scores 5 out of 10 in our fundamental rating. WGS was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for WGS as it has an excellent financial health rating, but there are worries on the profitability. WGS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year WGS was profitable.
In the past year WGS had a positive cash flow from operations.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
WGS has a Return On Assets of 0.42%. This is comparable to the rest of the industry: WGS outperforms 50.49% of its industry peers.
WGS has a Return On Equity of 0.71%. This is comparable to the rest of the industry: WGS outperforms 56.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.94%, WGS is in line with its industry, outperforming 42.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROIC | 1.94% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of WGS (0.52%) is comparable to the rest of the industry.
WGS has a Operating Margin (2.48%) which is comparable to the rest of the industry.
WGS has a better Gross Margin (69.65%) than 86.14% of its industry peers.
WGS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WGS is destroying value.
Compared to 1 year ago, WGS has more shares outstanding
Compared to 5 years ago, WGS has more shares outstanding
WGS has a better debt/assets ratio than last year.
2.2 Solvency
WGS has an Altman-Z score of 11.72. This indicates that WGS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.72, WGS belongs to the top of the industry, outperforming 94.06% of the companies in the same industry.
WGS has a debt to FCF ratio of 3.37. This is a good value and a sign of high solvency as WGS would need 3.37 years to pay back of all of its debts.
WGS's Debt to FCF ratio of 3.37 is fine compared to the rest of the industry. WGS outperforms 75.25% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that WGS is not too dependend on debt financing.
The Debt to Equity ratio of WGS (0.18) is better than 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.37 | ||
| Altman-Z | 11.72 |
ROIC/WACC0.22
WACC8.85%
2.3 Liquidity
A Current Ratio of 2.71 indicates that WGS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.71, WGS belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
WGS has a Quick Ratio of 2.59. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Quick ratio of 2.59. This is amongst the best in the industry. WGS outperforms 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 274.07% over the past year.
Looking at the last year, WGS shows a very strong growth in Revenue. The Revenue has grown by 50.50%.
Measured over the past years, WGS shows a quite strong growth in Revenue. The Revenue has been growing by 9.26% on average per year.
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
3.2 Future
The Earnings Per Share is expected to grow by 80.72% on average over the next years. This is a very strong growth
WGS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.73% yearly.
EPS Next Y644.01%
EPS Next 2Y177.61%
EPS Next 3Y132.41%
EPS Next 5Y80.72%
Revenue Next Year45.41%
Revenue Next 2Y33.46%
Revenue Next 3Y28.87%
Revenue Next 5Y26.73%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
WGS is valuated quite expensively with a Price/Earnings ratio of 88.09.
The rest of the industry has a similar Price/Earnings ratio as WGS.
WGS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.98.
The Price/Forward Earnings ratio is 93.43, which means the current valuation is very expensive for WGS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 60.40% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.79, WGS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.09 | ||
| Fwd PE | 93.43 |
4.2 Price Multiples
WGS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. WGS is more expensive than 64.36% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, WGS is valued a bit more expensive than the industry average as 60.40% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 304.04 | ||
| EV/EBITDA | 135.56 |
4.3 Compensation for Growth
WGS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WGS's earnings are expected to grow with 132.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y177.61%
EPS Next 3Y132.41%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
165.61
-1.9 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners110.59%
Inst Owner Change-4.76%
Ins Owners1.55%
Ins Owner Change0.63%
Market Cap4.76B
Revenue(TTM)402.19M
Net Income(TTM)2.08M
Analysts83.08
Price Target161.61 (-2.42%)
Short Float %13.92%
Short Ratio6.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)200.04%
Min EPS beat(2)14.73%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)260.69%
Min EPS beat(4)14.73%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)161.06%
EPS beat(12)9
Avg EPS beat(12)102.92%
EPS beat(16)12
Avg EPS beat(16)78.7%
Revenue beat(2)2
Avg Revenue beat(2)14.71%
Min Revenue beat(2)10.43%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)12.86%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)13.89%
Revenue beat(12)11
Avg Revenue beat(12)9.25%
Revenue beat(16)14
Avg Revenue beat(16)5.95%
PT rev (1m)28.04%
PT rev (3m)37.44%
EPS NQ rev (1m)-83.78%
EPS NQ rev (3m)-81.41%
EPS NY rev (1m)-7.21%
EPS NY rev (3m)9.49%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)3%
Revenue NY rev (1m)2.6%
Revenue NY rev (3m)2.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.09 | ||
| Fwd PE | 93.43 | ||
| P/S | 11.83 | ||
| P/FCF | 304.04 | ||
| P/OCF | 142.59 | ||
| P/B | 16.28 | ||
| P/tB | 44.52 | ||
| EV/EBITDA | 135.56 |
EPS(TTM)1.88
EY1.14%
EPS(NY)1.77
Fwd EY1.07%
FCF(TTM)0.54
FCFY0.33%
OCF(TTM)1.16
OCFY0.7%
SpS14
BVpS10.17
TBVpS3.72
PEG (NY)0.14
PEG (5Y)N/A
Graham Number20.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| ROCE | 2.45% | ||
| ROIC | 1.94% | ||
| ROICexc | 3.13% | ||
| ROICexgc | 11.96% | ||
| OM | 2.48% | ||
| PM (TTM) | 0.52% | ||
| GM | 69.65% | ||
| FCFM | 3.89% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 3.37 | ||
| Debt/EBITDA | 1.5 | ||
| Cap/Depr | 72.79% | ||
| Cap/Sales | 4.41% | ||
| Interest Coverage | 1.83 | ||
| Cash Conversion | 97.25% | ||
| Profit Quality | 750.55% | ||
| Current Ratio | 2.71 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 11.72 |
F-Score8
WACC8.85%
ROIC/WACC0.22
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)274.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1125%
EPS Next Y644.01%
EPS Next 2Y177.61%
EPS Next 3Y132.41%
EPS Next 5Y80.72%
Revenue 1Y (TTM)50.5%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%51.86%
Revenue Next Year45.41%
Revenue Next 2Y33.46%
Revenue Next 3Y28.87%
Revenue Next 5Y26.73%
EBIT growth 1Y117.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year681.51%
EBIT Next 3Y147.48%
EBIT Next 5YN/A
FCF growth 1Y107.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.52%
OCF growth 3YN/A
OCF growth 5YN/A
GENEDX HOLDINGS CORP / WGS FAQ
Can you provide the ChartMill fundamental rating for GENEDX HOLDINGS CORP?
ChartMill assigns a fundamental rating of 5 / 10 to WGS.
What is the valuation status of GENEDX HOLDINGS CORP (WGS) stock?
ChartMill assigns a valuation rating of 2 / 10 to GENEDX HOLDINGS CORP (WGS). This can be considered as Overvalued.
What is the profitability of WGS stock?
GENEDX HOLDINGS CORP (WGS) has a profitability rating of 3 / 10.
What is the financial health of GENEDX HOLDINGS CORP (WGS) stock?
The financial health rating of GENEDX HOLDINGS CORP (WGS) is 7 / 10.
What is the expected EPS growth for GENEDX HOLDINGS CORP (WGS) stock?
The Earnings per Share (EPS) of GENEDX HOLDINGS CORP (WGS) is expected to grow by 644.01% in the next year.